Masters Capital Management
Overview
Masters Capital Management is an SEC-registered investment adviser based in Atlanta, Georgia, founded in 1994. The firm operates as a hedge fund manager, employing a US-focused opportunistic investment strategy that primarily involves US equities and listed equity options. Their approach utilizes fundamental research and cyclical analysis, and may include short-term market timing and short selling. The firm manages several hedge funds, including the Marlin Fund and Sciens Blue Omega Cell.
Portfolio Companies
3
Website
masterscapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| BioCircuit Technologies | Sep 2022 | Seed | Lead |
| Celltaxis | Mar 2020 | Seed | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Masters Capital Management based?
Masters Capital Management is headquartered in Atlanta, Georgia, United States.
When was Masters Capital Management founded?
Founding year information for Masters Capital Management is not publicly available.
How many portfolio companies does Masters Capital Management have?
Masters Capital Management has 3 portfolio companies in Caplight's dataset.
What are some companies in Masters Capital Management's portfolio?
Portfolio companies visible on Caplight include BioCircuit Technologies, Celltaxis.
What was Masters Capital Management's most recent investment shown here?
Masters Capital Management's most recent investment in this portfolio sample was in BioCircuit Technologies in 2022.
What sectors does Masters Capital Management focus on?
Masters Capital Management focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Consumer & Commerce.
What company stages does Masters Capital Management focus on?
Masters Capital Management typically invests at the Early stage.
What is Masters Capital Management's AUM?
Masters Capital Management's assets under management are estimated between $648.0M and $2.6B.